Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Shu-Yein HoPo-Hong LiuChia-Yang HsuCheng-Yuan HsiaYun-Hsuan LeeRheun-Chuan LeeYi-Hsiang HuangFa-Yauh LeeMing-Chih HouYa-Ju TsaiTeh-Ia Huo

Published in: PloS one (2017)

Our data suggest that among the currently used liver reserve markers, ALBI grade may serve as an objective and feasible surrogate to predict the prognosis of HCC patients undergoing TACE.

Keyphrases

patients undergoing
radiofrequency ablation
big data
liver metastases
deep learning